WebFeb 1, 2024 · Alendronate is used to prevent and treat osteoporosis (thinning of the bone) in women after menopause. This medicine may also be used to increase bone mass in men who have osteoporosis, and in men and women to prevent and treat osteoporosis caused by long-term use of corticosteroids (cortisone-like medicine). WebAlendronate works best if taken on an empty stomach. Calcium or iron supplements , vitamins , antacids, coffee, tea, soda, mineral water, calcium -enriched juices, and food can decrease the ...
Effects of alendronate on bone quality and remodeling in
WebSimilar conclusions appear in an observational report in which oral alendronate (ALN) was administered to children and adolescents with OI (9, 10). The purpose of this study was to evaluate the efficacy and safety of daily oral ALN in the treatment of pediatric OI through a 2-yr, randomized, placebo-controlled, multicenter study. WebThere are 109 drugs known to interact with alendronate, along with 7 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 2 are major, 102 are moderate, and 5 are minor. Does alendronate interact with my other drugs? Enter other medications to view a detailed report. palisade solutions
Alendronate SODIUM Tablet Osteoporosis Agents - WebMD
WebFeb 1, 2024 · Precautions. If you will be taking this medicine for a long time, it is very important that your doctor check your progress at regular visits to make sure this medicine is working properly and watch for unwanted effects. This medicine can irritate your esophagus. Call your doctor right away if you think this medicine has started to damage your ... WebAlendronate; In a 48-week prospective, randomized, open-label study of alendronate (70 mg once weekly) administered in combination with calcium …. Osteoporosis after solid organ or stem cell transplantation. …trial of 98 patients receiving a liver transplant, subjects randomly assigned to alendronate (70 mg weekly) versus no alendronate had ... WebEffects of alendronate (ALN) on bone quality and turnover were assessed in 88 patients (52 women and 36 men aged 22-75 years) who received long-term oral glucocorticoid exposure. Patients were randomized to receive oral placebo or alendronate 2.5, 5, or 10 mg/day for 1 year and stratified according … palisades nj county